As the 2026 interim report season approaches, several ST companies have announced their anticipated shift from loss to profit. However, this financial recovery is juxtaposed with the pressure of investor compensation claims stemming from past financial misconduct and information disclosure violations.

A Look at Several ST Stocks with Profit Forecasts

As of July 16th, a total of 17 ST stocks are forecasted to be profitable for the first half of 2026. Among these, 11 are subject to investor compensation claims due to violations, though it should be noted that some data is sourced from the internet and may be incomplete.

Here is a detailed breakdown:

ST Tianji expects a net profit between 220 million and 260 million yuan for the first half, topping the list of ST companies with profit forecasts. This is primarily attributed to the recovery in profitability of its core product, lithium hexafluorophosphate.

ST Xiwang anticipates a profit of 200 million to 250 million yuan, mainly resulting from investment gains of approximately 350 million yuan generated from the disposal of Iovate assets.

ST Wanbang projects a profit ranging from 65 million to 90 million yuan, representing a year-on-year increase of 382.79% to 568.47%.

ST Jinglan forecasts a profit between 68 million and 83 million yuan, largely driven by 76 million yuan in non-recurring gains from its subsidiary's disposal of company shares.

ST Haiqin expects to earn between 16 million and 24 million yuan, benefiting from improved performance in its liquefied petroleum gas business compared to the previous year.

*ST Huawen estimates a profit of 47 million to 60 million yuan, aided by restructuring gains of about 100 million yuan.

ST Changyuan anticipates profits between 35 million and 52 million yuan, with its smart grid equipment business showing steady growth.

*ST Sanfang forecasts a profit from 4.9 million to 5.9 million yuan, as an improved industry supply-demand dynamic has bolstered its main operations.

*ST Liuhua expects a profit of 14 million yuan, with a favorable hydrogen peroxide market driving significant earnings growth.

ST Longyun projects a profit between 3.7 million and 5.5 million yuan, as ongoing staff optimization and cost-reduction measures continue to yield results.

*ST Xiangyou estimates a profit ranging from 2.4 million to 3.5 million yuan, following the successful recovery of some receivables.

Profitability Does Not Eliminate Claim Risk

Despite the positive forecasts, these companies are not without concerns. For some, the very reason for their special treatment status stems from past violations, which now serves as the legal basis for investor compensation claims. A few examples illustrate this point.

ST Tianji was subjected to other risk warnings due to financial fraud violating relevant laws and regulations. To meet performance commitments, its acquired subsidiary, Changshu Xinte Chemical Co., Ltd., prematurely recognized revenue between November and December 2023 by self-signing delivery orders and arranging for customers to fill out documents and issue invoices in advance.

ST Wanbang received its ST designation on May 6, 2026. This followed a negative opinion audit report issued by Beijing Dehao International Accounting Firm on the internal controls of Wanbangde for the 2025 fiscal year. The audit firm discovered a substantial volume of fund flows with questionable commercial rationale within the company's accounts.

*ST Liuhua faced its designation due to a significant earnings reversal. On April 10, 2026, the company issued a corrected 2025 earnings forecast, abruptly changing from an initially projected profit exceeding 6 million yuan to a substantial loss of 30 million yuan. By simultaneously triggering the two strict criteria of "negative net profit" and "revenue below 300 million yuan," the company was labeled with *ST.

While financial performance can improve in the short term, sustainable market trust for listed companies is built on compliance and honest disclosure.

Affected Investors Can Seek Legal Recourse

Legal counsel indicates that, according to the Securities Law and related judicial interpretations, investors who have suffered losses due to false statements by listed companies have the right to file civil compensation lawsuits. Eligible investors who have incurred losses should pay close attention to the statute of limitations for claims and actively pursue their rights through legal channels.

The profit forecasts of the aforementioned companies, driven by industry recovery, asset disposals, or restructuring gains, are a positive sign of fundamental improvement. However, the historical violations constitute established legal facts, making the compensation demands of affected investors both reasonable and lawful.